Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

NCT02521311 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Optic Neuritis

Interventions

DRUG: Clemastine
DRUG: Placebo

Sponsor

University of California, San Francisco

Collaborators

[object Object]